May 2024 SOCRA Source Journal - Journal - Page 52
References (continued
Greenwood, C., Metodieva, G., Al-Janabi, K., Lausen, B., Alldridge, L., Leng, L., Bucala, R., Fernandez, N. and
Metodiev, M. V. (2012) ‘Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and
lymph node metastasis in triple-negative breast cancer’, Journal of Proteomics, 75(10), 3031-3040.
Group, E. B. C. T. C. (2015) ‘Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level metaanalysis of the randomised trials’, The Lancet, 386(10001), 1341-1352.
Gupta, P. B., Proia, D., Cingoz, O., Weremowicz, J., Naber, S. P., Weinberg, R. A. and Kuperwasser, C. (2007)
‘Systemic stromal effects of estrogen promote the growth of estrogen receptor–negative cancers’, Cancer
Research, 67(5), 2062-2071.
Hickey, T., Robinson, J., Carroll, J. and Tilley, W. (2012) ‘Minireview: the androgen receptor in breast tissues:
growth inhibitor, tumor suppressor, oncogene?’, Molecular Endocrinology, 26(8), 1252-1267.
Hix, L. M., Karavitis, J., Khan, M. W., Shi, Y. H., Khazaie, K. and Zhang, M. (2013) ‘Tumor STAT1 transcription
factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived
suppressor cells’, Journal of Biological Chemistry, 288(17), 11676-11688.
Hoeijmakers, J. H. (2001) ‘Genome maintenance mechanisms for preventing cancer’, Nature, 411(6835), 366.
Hubalek, M., Czech, T. and Müller, H. (2017) ‘Biological subtypes of triple-negative breast cancer’, Breast Care,
12(1), 8-14.
Hwang, S., Thumar, J., Lundgren, D., Rezaul, K., Mayya, V., Wu, L., Eng, J., Wright, M. and Han, D. (2007)
‘Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-昀椀xed
paraf昀椀n-embedded archival tissues’, Oncogene, 26(1), 65-76.
Ihle, J. N. (2001) ‘The Stat family in cytokine signaling’, Current Opinion in Cell Biology, 13(2), 211-217.
Ismail-Khan, R. and Bui, M. M. (2010) ‘A review of triple-negative breast cancer’, Cancer Control: Journal
of the Mof昀椀tt Cancer Center, 17(3), 173.
Iwamoto, T., Booser, D., Valero, V., Murray, J. L., Koenig, K., Esteva, F. J., Ueno, N. T., Zhang, J., Shi, W.
and Qi, Y. (2012) ‘Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are
1% to 10% ER-positive by immunohistochemistry’, J Clin Oncol, 30(7), 729-734.
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O.
and Gelmon, K. (2010) ‘Metastatic behavior of breast cancer subtypes’, Journal of Clinical Oncology, 28(20),
3271-3277.
Khodarev, N. N., Beckett, M., Labay, E., Darga, T., Roizman, B. and Weichselbaum, R. R. (2004) ‘STAT1 is
overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced
sensitive cells’, Proceedings of the National Academy of Sciences of the United States of America, 101(6),
1714-1719.
Kovacic, B., Stoiber, D., Moriggl, R., Weisz, E., Ott, R. G., Kreibich, R., Levy, D. E., Beug, H., Freissmuth, M.
and Sexl, V. (2006) ‘STAT1 acts as a tumor promoter for leukemia development’, Cancer Cell, 10(1), 77-87.
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y. and Pietenpol, J. A. (2011)
‘Identi昀椀cation of human triple-negative breast cancer subtypes and preclinical models for selection of targeted
therapies’, The Journal of Clinical Investigation, 121(7), 2750.
52
SOCRA SOURCE © May 2024